Latest News

Four Yale School of Medicine trainees received Conquer Cancer Foundation Young Investigator Awards at the American Society of Clinical Oncology annual meeting.

Why do some lung cancers stop responding to drugs that once worked? And why does the immune system sometimes fail to recognize and destroy tumors? Pathologist Katerina Politi, PhD, has spent more than two decades pursuing those questions, and her team at Yale School of Medicine is now closer to finding answers that could reshape how patients are treated.

On Tuesday, April 7, 2026, the Center for Thoracic Cancers hosted a special event for patients and caregivers, with Annabelle Gurwitch.

On November 17, 2025, in honor of Lung Cancer Awareness Month, members of our Center for Thoracic Cancers at Smilow Cancer Hospital and Yale Cancer Center presented a patient forum: "Progress and Hope: Sharing the Latest Advances in Lung Cancer Care." The event was held in person at 55 Park Street in New Haven, CT.

Dr. Roy Herbst shares the progress that has been made in lung cancer care and research at Smilow Cancer Hospital and Yale Cancer Center.

An intensive two-day Yale Cancer Research symposium, dedicated to advancing cancer science through innovation and strengthening partnerships between Yale University and Historically Black Colleges and Universities (HBCUs), brought together researchers from multiple disciplines this week.

Yale Cancer Center's Specialized Program of Research Excellence (SPORE) in Lung Cancer has been awarded a renewal grant from the National Cancer Institute (NCI) for year 11 of the program. The prestigious grant, totaling $12M over five years, will provide critical funding to advance groundbreaking lung cancer research and accelerate progress in the prevention, detection, and treatment of this disease.

In honor of National Cancer Research Month, Dr. Katerina Politi shares why her research is focused on cancer.

Yale Cancer Center joined Hill Day, hosted by the American Association for Cancer Research (AACR) and the Association of American Cancer Institutes (AACI) to bring cancer center directors, researchers, physician-scientists, cancer survivors, and other advocates together to build support for a strong federal investment in biomedical research—and cancer research in particular—through the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Hill Day is a special opportunity in that it helps members of cancer centers secure time to meet with their Congressional representatives to share the importance and impact of cancer funding.